Overview
Familial isolated hypoparathyroidism due to impaired PTH secretion is a rare inherited endocrine disorder characterized by low or absent parathyroid hormone (PTH) secretion in the absence of other associated developmental or autoimmune abnormalities. Unlike syndromic forms of hypoparathyroidism (such as DiGeorge syndrome or autoimmune polyendocrinopathy), this condition affects the parathyroid glands in isolation, resulting in deficient PTH production or release despite structurally present parathyroid tissue. PTH is essential for maintaining calcium and phosphorus balance in the body, and its deficiency leads to hypocalcemia (low blood calcium) and hyperphosphatemia (high blood phosphorus). The condition primarily affects the endocrine and neuromuscular systems. Key clinical features include muscle cramps, tingling and numbness in the hands, feet, and around the mouth (paresthesias), muscle spasms (tetany), and in severe cases, seizures due to critically low calcium levels. Chronic hypocalcemia can also lead to calcification of the basal ganglia in the brain, cataracts, dental abnormalities, and cardiac rhythm disturbances. Symptoms may present in infancy, childhood, or later in life depending on the specific genetic cause and severity of the PTH secretion defect. Several genetic causes have been identified, including mutations in the PTH gene itself, the GCM2 (GCMB) gene which is a transcription factor critical for parathyroid gland development and function, and gain-of-function mutations in the calcium-sensing receptor (CASR) gene that cause the parathyroid glands to inappropriately suppress PTH secretion at normal or low calcium levels. Treatment consists of lifelong supplementation with oral calcium and active vitamin D analogs (such as calcitriol or alfacalcidol) to maintain serum calcium levels within an acceptable range. Recombinant PTH (such as teriparatide or PTH 1-84) may be considered in refractory cases. Regular monitoring of serum calcium, phosphorus, renal function, and urinary calcium excretion is essential to prevent complications such as nephrocalcinosis and kidney stones.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Familial isolated hypoparathyroidism due to impaired PTH secretion.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial isolated hypoparathyroidism due to impaired PTH secretion at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial isolated hypoparathyroidism due to impaired PTH secretion.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Familial isolated hypoparathyroidism due to impaired PTH secretion.
Community
No community posts yet. Be the first to share your experience with Familial isolated hypoparathyroidism due to impaired PTH secretion.
Start the conversation →Latest news about Familial isolated hypoparathyroidism due to impaired PTH secretion
No recent news articles for Familial isolated hypoparathyroidism due to impaired PTH secretion.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial isolated hypoparathyroidism due to impaired PTH secretion
What is Familial isolated hypoparathyroidism due to impaired PTH secretion?
Familial isolated hypoparathyroidism due to impaired PTH secretion is a rare inherited endocrine disorder characterized by low or absent parathyroid hormone (PTH) secretion in the absence of other associated developmental or autoimmune abnormalities. Unlike syndromic forms of hypoparathyroidism (such as DiGeorge syndrome or autoimmune polyendocrinopathy), this condition affects the parathyroid glands in isolation, resulting in deficient PTH production or release despite structurally present parathyroid tissue. PTH is essential for maintaining calcium and phosphorus balance in the body, and its